Hangzhou Clongene Biotech Co., Ltd., founded in 2004, is a leading national high-tech manufacturer specializing in biological raw materials and in vitro diagnostic (IVD) products. Based in Hangzhou, China, the company operates state-of-the-art R&D and manufacturing facilities spanning 19,000 square meters, including a 10,000+ m² GMP-compliant production workshop. With a workforce of over 500 employees and more than 10 production lines, the company achieves an annual output of 500 million rapid test pieces, serving major domestic IVD manufacturers and international partners in over 100 countries.
Clungene Leptospira Igg/Igm Rapid Test$0.7
Group a Streptococcus (GAS) Streptococcus a (Strep A) Rapid Test Clungene Lungene Clongene Antigen Rapid Test Kit Uncut Sheet$0.5
Mouse Anti-Malaria P. Falciparum-HRP 2 MAb Monoclonal Antibody for Malaria Antigen Rapid Test Further Manufacturing$30
Bovine Cow Pag Pregnancy Rapid Test Uncut Sheet Diagnostic Test Kit$1.5
Clungene Rsv Respiratory Syncytial Virus Antigen Rapid Diagnostic Test or Uncut Sheet$0.7
Hangzhou Molecular Biotech Co., Ltd.
🇨🇳 China
202111-50 peopleManufacturer/Trading Company
Own brand
Patented technology
High-tech enterprise
Low MOQ
Key market
Africa
Description
Hangzhou Molecular Biotech Co., Ltd. is a professional biotechnology enterprise specializing in the research, development, and supply of instruments, reagents, and consumables for genetic testing and molecular diagnostics. Based in Hangzhou, China, the company operates as a key subsidiary of Shanghai Molecular Biomedical Technology Co., Ltd., functioning as part of an integrated group that includes specialized manufacturing and sales entities. The company serves as both a manufacturer and trading company, offering comprehensive OEM, ODM, and contract manufacturing services to the global market.
The company's core technological portfolio features industry-leading platforms, including the Micro-Chamber Controlled Nucleic Acid Diagnostic System (MCC) and rapid real-time fluorescence quantitative PCR (POCT-qPCR) systems. Their extensive product range includes handheld PCR devices, nucleic acid extraction systems, microfluidic chips, ELISA kits, and high-end laboratory consumables such as disposable sampling swabs and Taq DNA polymerase. These solutions are widely applied in medical diagnosis, scientific research, disease prevention, animal and plant quarantine, and forensic identification.
Supported by a parent group that maintains over 5,000 square meters of R&D centers and cleanroom facilities, Hangzhou Molecular Biotech utilizes modern production and assembly systems capable of producing all categories of in-vitro diagnostic reagents. The organization is driven by scientific innovation, backed by more than ten invention patents and a dedicated team of R&D professionals. With an annual output value reaching up to US$2.5 million, the company is committed to establishing a leading position in the international molecular diagnostics field through professional innovation and pragmatic efficiency.